Molecules 2007, 12
995
Yamamoto, N.; Tsukiyama, T.; Ino, A.; Okita, T. Methodologies for synthesis of heterocyclic
compounds. J. Heterocycl. Chem. 1992, 29, 619-625; (c) Michael, J.P. Quinoline, quinazoline
and acridone alkaloids. Nat. Prod. Rep. 1997, 14, 605-608.
7. (a) Markees, D.G.; Dewey, V.C.; Kidder, G.W. Antiprotozoal 4-aryloxy-2-aminoquinolines and
related compounds. J. Med. Chem. 1970, 13, 324-326; (b) Alhaider, A.A.; Abdelkader, M.A.;
Lien, E.J. Design, synthesis and pharmacological activities of 2-substituted 4-phenylquinolines as
potential antidepressant drugs. J. Med. Chem. 1985, 28, 1394-1398; (c) Campbell, S.F.;
Hardstone, J.D.; Palmer, M.J. 2,4-Diamino-6,7-dimethoxyquinoline derivatives as α 1-
adrenoceptor antagonists and antihypertensive agents. J. Med. Chem. 1988, 31, 1031-1305.
8. Abegg, R. Amidochrysene. Ber. 1890, 23, 792-793.
9.
Bamberger, E.; Burgdorf, C. Chrysene. Ber. 1890, 23, 2433-2446.
10. (a) Castro, A.; Martinez, A. Peripheral and binding site acetylcholinesterase inhibitors:
implications in treatment of Alzheimer’s disease. Mini-Rev. Med. Chem. 2001, 1, 267-272; (b)
Silman, I.; Sussman, J.L. Acetylcholinesterase: “classical” and “non-classical” functions and
pharmacology. Curr. Opin. Pharmacol. 2005, 5, 293-302; (c) Munoz-Torrero, D.; Camps, P.
Dimeric and hybrid anti-Alzheimer drug candidates. Curr. Med. Chem. 2006, 13, 399-422.
11. (a) Denmark, S.E.; Venkatraman, S. On the Mechanism of the Skraup-Doebner-Von Miller
Quinoline Synthesis. J. Org. Chem. 2006, 71, 1668-1676; (b) Kamiguchi, S.; Takahashi, I.;
Kurokawa, H.; Miura, H.; Chihara, T. Vapor-phase synthesis of 1,2-dihydro-2,2,4-
trimethylquinolines from anilines and acetone over group 5-7 metal halide clusters as catalysts.
Appl. Catal., A. 2006, 309, 70-75; (c) Wu, Y.-C.; Liu, L.; Li, H.-J.; Wang, D.; Chen, Y.-J.
Skraup-Doebner-Von Miller Quinoline Synthesis Revisited: Reversal of the Regio-chemistry for
γ-Aryl-β,γ-unsaturated α-Ketoesters. J. Org. Chem. 2006, 71, 6592-6595; (d) Ku, Y.Y.; Grieme,
T.; Raje, P.; Sharma, P.; Morton, H.E.; Rozema, M.; King, S.A. A practical and scaleable
synthesis of A-224817.0, a novel nonsteroidal ligand for the glucocorticoid receptor. J. Org.
Chem. 2003, 68, 3238-3240.
12. (a) Ihara, E.; Koyama, K.; Yasuda, H.; Kanehisa, N.; Kai. Y. Catalytic activity of allyl-, azaallyl-
and diaza-pentadienyllanthanide complexes for polymerization of methyl methacrylate. J.
Organomet. Chem. 1999, 574, 40-49; (b) Kelly, T.R.; Chandrakumar, N.S.; Saha, J.K. A chiral
catechol with C2 symmetry. J. Org. Chem. 1989, 54, 980-983; (c) Phillips, J.P.; Elbinger, R.L.;
Merrit, L.L. Preparation of some substituted 8-hydroxy-and 8-methoxyquinolines. J. Am. Chem.
Soc. 1949, 71, 3986-3988; (d) Volz, H.; Hassler, M. meso-Substituted porphyrins. 5. Basket
porphyrins. Z. Naturforsch. 1988, 43b, 1043-1052.
13. Delapierre, G.; Brunel, J.M.; Constantieux, T.; Buono, G. Design of a new class of chiral
quinoline-phosphine ligands. Synthesis and application in asymmetric catalysis. Tetrahedron:
Asymm. 2001, 12, 1345-1352.
14. (a) Padmavathi, V.; Reddy, B.J.M.; Sarma, M.R.; Padmaja, A.; Reddy, D.B. Cyclohexanone
derivatives: synthons for substituted quinolines. Heterocycl. Commun. 2001, 7, 467-472; (b)
Padmavathi, V.; Reddy, B.J.M.; Balaiah, A.; Reddy, K.V.; Reddy, D.B. Synthesis of some fused
pyrazoles and isoxazoles. Molecules 2000, 5, 1281-1286.